• Telco capital expenditures of $150 billion are planned through 2023
• Aerospace companies are also spending on 5G
• Spectrum recently secured a key, two-year nationwide contract with a Tier-1 infrastructure aggregator

It’s not just telecommunications companies that are opening their businesses – and wallets – to 5G. Space companies are investing in 5G technology too, which means good things for companies such as Spectrum Global Solutions Inc. (OTCQB: SGSI). Lured by the faster speeds and lower latencies of 5G, Boeing, SpaceX and other aerospace companies hope to increase the range of telecommunications possible through satellite, which is good enough for phone calls and TV but can’t handle data-intensive applications like streaming video – à la Netflix – very well.

Harnessing those advantages, however, requires investment in costly new innovations. As a result, what started as a trickle of dollars for 5G infrastructural development has now turned into a flood. That influx of funds means infrastructure aggregator Spectrum can look ahead to a bright future as it continues to build and service end-to-end communications networks at home and abroad.

It may seem strange that aerospace companies are venturing into 5G. But some of those companies build telecommunications satellites, and anything that increases satellite capability, such as 5G, is good for business. New technologies such as electronic product codes (EPC), data orchestration and 5G New Radio are bringing 5G closer to the masses.

An EPC is a unique identifier for physical objects that can be used to track the object in a supply chain. EPCs are designed to be stored on a radio-frequency identification (RFID) tag and may be associated with dynamic data such as the origination point of an item or the date of its production. Data orchestration is the automation of data-driven processes to achieve an integrated workflow. 5G New Radio (NR) is the global standard for the 5G wireless air interface, or the radio-frequency portion of the connection between a mobile phone and the cell tower. 5G NR opens up the spectrum above 6 GHz, which was previously unusable by cellular services.

The rollout of 5G networks is expected to create three million American jobs and add half a trillion dollars to U.S. GDP, according to global-management consultant Accenture. Spectrum has already been selected to play a part, based on its global track record of successfully executing more than 150,000 projects. Since commencing operations 34 years ago, the company has delivered cost-effective, scalable, robust solutions for communication carriers, utilities, enterprise companies, OEMs and others. And as 5G infrastructure spending increases, SGSI’s opportunity pipeline has swollen to $137 million.

Spectrum serves the biggest and the best in the industry including major carriers such as AT&T, Sprint, T-Mobile and Verizon; aggregators such as American Tower, Crown Castle, Zayo and ExteNet; and big-name OEMs such as Ericsson, Nokia and Samsung. The company’s longstanding relationships generate repeat business at minimal acquisition cost. As the shift to 5G progresses, telecom CAPEX upgrades are forecast to hit $150 billion by 2023.

As evidence of the potential, Spectrum recently won a key two-year nationwide engineering services contract to support the 5G network deployment initiatives of a Tier-1 infrastructure aggregator. The contract is for outside plant engineering services surrounding an optical fiber-fed, 200-plus site, metropolitan-area, 5G infrastructure deployment (http://ibn.fm/JBap4).

“We are pleased to announce another Tier-1 contract win supporting the rollout of a 5G network in a major metropolitan area in the United States,” Spectrum Global Solutions President Keith Hayter stated in a news release. “We continue to see ramping demand for our services to power the 5G connectivity revolution, the infrastructure spending for which we expect to continue unabated for the next several years.”

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI

• ChineseInvestors.com  CEO recently discussed its corporate initiatives in a MoneyTV segment
• The company’s subsidiary, CBD Biotech, has expanded into seven strong Asian markets
• ChineseInvestors.com offers a diverse menu of investor education products and services

ChineseInvestors.com Inc. (OTCQB: CIIX) has become a foremost financial information website for Chinese-speaking investors around the world. Through its main website, www.ChineseInvestors.com, it provides an array of investor education products and services. In addition, the company’s CBD division, CBD Biotech Inc., has experienced tremendous growth. Recently, CIIX CEO Warren Wang discussed the focus of the company on MoneyTV with Donald Baillargeon (http://ibn.fm/vxRIS). In an effort to maximize transparency with investors, Wang provided an overview of the company’s two business strands.

Wang noted that CIIX’s main business, accounting for 60-70 percent of its revenue streams, is its investor relations business. This segment of the company offers a variety of services to clients. With a main office in New York, its experienced executive team is headed by service director Angel Feng. Over the last six years, ChineseInvestors.com has accrued close to 100 IR (investor relations) clients, organized road shows, launched its own television channel with Phoenix TV, conducted radio shows, and managed social media platforms.

Wang notes that ChineseInvestors.com helps its clients expand their shareholder base. Additionally, the company’s subscription division, a live broadcast set during market hours, allows members to connect with professors who are experienced in navigating the stock market. He added that members enjoy this interactive program and appreciate the education provided in how to trade options on the market. This valuable program is enabling ChineseInvestors.com to build its customer and investor database.

While the company continues to roll out new products and services, its present plan is to emphasize its original mission of providing financial information and services to the larger Chinese community in the United States and elsewhere (http://ibn.fm/jvr8b). With offices in San Gabriel, California; Flushing, New York; and Shanghai, China, ChineseInvestors.com is well-positioned to achieve this goal. “While we have been strategically focusing on industrial hemp and CBD sales, we are pleased with the progress we have seen in our legacy businesses, financial news, education subscriptions, and investor relations, where we are re-focused on organic growth,” Wang said recently.

In reference to the company’s rapidly growing CBD division, the company hopes for a Nasdaq IPO of CBD Biotech late in FY2019 or early in 2020. Moreover, the company’s CBD Biotech subsidiary has expanded into six new countries and a new region of China (http://ibn.fm/JP23E) and is laying a foundation to capitalize on growing demand for CBD-based nutrition and health products. Growth via acquisition will be a priority following an initial public offering spin-off of CBD Biotech (http://ibn.fm/g9Uvp).

On the MoneyTV segment, Wang also discussed how the company’s stock price has stabilized because of enhanced communication between company leaders and the company’s mainstream shareholders. Referencing the OTC market, Wang described it as a “very liquid market,” noting that volumes can be quite diverse from day to day. However, referencing American business magnate Warren Buffet, Wang described Buffet seeking out the OTC market first when considering an investment as the OTC is a “value stock vehicle.” Wang’s goal is that the market will recognize the significant value in ChinesInvestors.com. He wished his investors the best, hoping they will be patient with all the company is working to accomplish.

For investors, ChineseInvestors.com offers a window of opportunity for ROI with its two-pronged approach to growth and profits. This past June, company leaders anticipated CIIX doubling it sales over the next year. ChineseInvestors.com continues to focus on becoming the top financial information website for Chinese-speaking investors globally.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• SRAX’s CEO presented at the Microcap Rodeo Investor Conference held October 15 in Austin, Texas
• The company’s BIGtoken offers an innovative way for consumers to own and earn from their data
• The company aims to become a household name in the data management sector

SRAX Inc. (NASDAQ: SRAX) CEO Christopher Miglino presented at the Microcap Rodeo Investor Conference held at the Hilton Austin Downtown in Austin, Texas on October 15. The theme of the conference, ‘Lassoing the Best Ideas’, aptly encompasses SRAX. SRAX’s innovative strategy to solve the problem of consumer consent to release data is aiding it in its quest to build the largest opted-in data set in the world.

SRAX’s innovative BIGtoken platform requests permission from its users for data sharing when those users sign up on the platform (http://ibn.fm/LbKG2). SRAX is ahead of the competition in using this approach. In California, a new privacy law compliance bill goes into effect January 1, 2020, requiring users to provide this permission before their information can be shared. The law is designed to protect the privacy of consumers, a responsibility SRAX has taken seriously since the inception of its BIGtoken app.

A recent CNBC report noted that the legislation could mean that some firms may have to pay in aggregate up to $55 million in initial compliance costs, according to an assessment prepared by an independent research firm for the state attorney general’s office in California (http://ibn.fm/LrIWb). Thanks to BIGtoken, SRAX is already in compliance with the legislation.

SRAX is a digital marketing and consumer data management technology company that has developed a first-of-its-kind data management platform. The company’s proprietary BIGtoken platform offers a secure and transparent environment for consumers to own and earn from their data (http://ibn.fm/jXGBN). The SRAX product offers consumers key control over their own privacy and also unlocks the value of their data. The Microcap Rodeo Investor Conference (http://ibn.fm/pYQAc) offered investors the firsthand opportunity to hear details about BIGtoken and the company’s strategy from Miglino himself.

The annual Austin conference offers investors the chance to harness top stocks for their portfolios. Executive management teams from more than 50 microcap companies across a wide variety of industries attended this year’s event, which featured four tracks of diverse company presentations along with an interactive, in-depth format of face-to-face meetings.

SRAX’s technology dually benefits both individual consumers and the companies seeking to utilize their data. For the latter, SRAX sells access to data in the form of anonymized segments. BIGtoken unlocks data to reveal the core customers of brands and the characteristics of those consumers across marketing channels. Individual consumers utilize the BIGtoken platform to control access to their information at any time. By creating a mutually beneficial way to help consumers market themselves while also protecting their privacy, the company is building the largest and most valuable opted-in data set worldwide. Through the added exposure gained from Miglino’s appearance at the Microcap Rodeo Investor Conference, the company is poised to become a household name in the data management sector.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at  http://ibn.fm/SRAX

• TGOD is the only licensed producer to grow certified organic cannabis at scale
• The Green Organic Dutchman’s processes are certified by two of the largest organic certification organizations in the world
• The company’s certified-organic process benefits consumers, the community and the environment

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), a global leader in cultivating premium, certified organic cannabis, prides itself on its commitment to producing premium organic cannabis. The company is the only Licensed Producer to grow certified organic cannabis at scale. Maintaining that commitment isn’t easy, but TGOD’s higher standard of organic growing has attracted a strong base of customers who value being able to trust that their products are cultivated in accordance with Canadian organic standards and are not irradiated.

TGOD’s decision to go organic is rooted in the company’s desire to provide its consumers with the highest-quality, healthiest options on the market. The Green Organic Dutchman understands that, for many, cannabis is a life-changing medicine. Patients and consumers alike have no desire to ingest irradiated products.

In addition, research indicates that more than 55 percent of Canadian consumers purchase organic products on a weekly basis, and over 80 percent of those maintained – or increased – their organic purchases in the last year. With that kind of consumer base, along with organic trends growing around the world and its dedication to providing only the best, TGOD’s decision to go organic was a no-brainer.

Growing certified-organic cannabis doesn’t just benefit consumers. The process is also better for the community, the soil and the environment. TGOD’s cultivation process includes creating a living soil designed to build a population of beneficial organisms that provide an enhanced diversity of biology in the soil. That means that when TGOD “hands over the power to the flower,” the plant teams up with the right fungi and healthy bacteria to grow the highest-quality cannabis available.

In an era where the term “organic” is often thrown about casually, clients appreciate knowing that TGOD’s organic claims are officially recognized. TGOD’s processes are certified by both ECOCERT and Pro-Cert, two of the largest organic certification organizations in the world. ECOCERT standards are based on natural and organic principles, including the use of ingredients derived from renewable resources and environmentally friendly process. Pro-Cert’s certification is ISO 17065 compliant and accredited.

While TGOD is committed to being a global leader in certified organic cannabis, the company’s goal is also to create a positive economic impact locally. The company’s community farm produces fresh organic food that it contributes through food donation programs. Finally, because growing organically focuses on the natural growth of the plant, it is a cleaner process. Through its regenerative farming practices, TGOD also reduces its carbon footprint throughout the entire product life cycle.

The Green Organic Dutchman is a publicly traded, premium-cannabis producer in Canada, engaged in growing organic cannabis using craft farming techniques. The company operates in medical cannabis markets in Canada, Europe, the Caribbean, and Latin America, and also supplies to the Canadian adult-use market. TGOD also operates in the CBD-oil markets of Canada and distributes premium-hemp CBD oil in the European Union through its wholly owned subsidiary HemPoland.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at  http://ibn.fm/TGODF

• VPR Brands commissioned a report outlining where 2020 presidential hopefuls stand on legalizing cannabis in an effort to promote a strong cannabis industry
• The company continues to execute its growth plan by adding products, adding customers and increasing sales
• VPR Brands recorded an increase in quarterly revenues, a lowered net loss and a strong gross operating margin

As America looks toward the 2020 election, one key issue is weighing on the minds of companies and employees within the cannabis industry. Which candidates seek to make cannabis legal and to see the industry thrive?

VPR Brands LP (OTCQB: VPRB), a technology holding company specializing in vaporizers and accessories for essential oils, cannabis concentrates, extracts, and electronic cigarettes containing nicotine, shows revenue and product potential to compete with larger companies on the OTC in the cannabis sector. The company’s Q1 2019 report (http://ibn.fm/6WVql) announced a 31 percent year-over-year increase in quarterly revenues, a lowered net loss, and a strong gross operating margin above 40 percent. As VPRB continues to invest in inventory and new products to keep up with increased demand, it is only natural that its leadership keep a close eye on the presidential debate stage.

Kevin Frija, the CEO of VPRB, commissioned a report (http://ibn.fm/IXAzA) to outline where the 2020 presidential hopefuls stand on this critical issue. Journalist William Freedman was sponsored by VPRB to investigate what the nearly 30 candidates have been saying and doing about cannabis’ future in America. The purpose of the report was to provide clear, factual data to voters interested in the cannabis industry.

The resulting landmark study, titled ‘The VPR Brands Voters’ Guide to 2020 U.S. Presidential Candidates on Cannabis Issues’, can be read in its entirety at www.VPRBrands.com/Cannabis-Vote-2020.

As the cannabis industry continues to flourish and grow, becoming a major contributor to both local and global economies, political figures can no longer afford to ignore or demonize it. Indeed, this is the first presidential election where candidates have been willing to take on controversial public positions on cannabis issues, and many are utilizing all avenues to do so: from the presidential debate stage to their personal social media accounts. On October 15, 2019 in the middle of the Ohio democratic debate, Beto O’Rourke tweeted, “Legalize marijuana” (http://ibn.fm/JG5Hs) with a follow-up image promoting legalization (http://ibn.fm/H2xQg).

A light-hearted exchange (http://ibn.fm/OG6Re) between Cory Booker and Bernie Sanders where the latter joked he was not “on [medicinal marijuana] tonight” further highlights the shifting public attitudes toward the burgeoning industry that was once marginalized to shadowy back alleys. As big pharmaceutical companies are coming under fire for the growing opioid crisis, people and politicians are looking to cannabis as part of the solution (http://ibn.fm/j1UNy).

VPRB’s commissioned report outlined four cultural shifts in America in regard to cannabis over the past decade. They are:

1. Acceptance of CBD and THC for both medical and recreational use
2. Recognition that the laws prohibiting their sale and possession might be disproportionate to the harm to society
3. Acquiescence in one-time tobacco-growing states that industrial hemp could serve as a replacement cash crop
4. Realization that no business can be fully legitimized until banks can provide it financing without fear of losing their federal charters

Reexamination of cannabis policy at the federal level is necessary for the industry to thrive. As the federal government catches up, VPRB continues to drive growth by adding products, adding customers, and increasing sales. In 2019 a major growth initiative has been to drive revenue through ecommerce, which has brought in approximately 10 period of VPRB’s total revenue. They continue to seek out strategic partnerships, drive organic customer growth, and stay on the forefront of innovation.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at  http://ibn.fm/VPRB

• Lexaria Bioscience Corp. continues to make progress in the patenting and development of its DehydraTECH™ platform
• Lexaria developed the patented DehydraTECH™ drug delivery platform as a safer alternative to inhalation of nicotine or cannabinoids
• DehydraTECH™ has been shown to facilitate rapid uptake and highly targeted delivery of pharmaceuticals to the brain

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has levered innovation, research and development into operations in four market verticals: cannabis, hemp, nicotine, and pharmaceuticals. Lexaria already introduced the DehydraTECH™ drug delivery platform into commercial use and has a second-generation delivery platform ready for launch in 2020. Lexaria is the only company in the world to receive a patent for this improved oral delivery of all non-psychoactive cannabinoids including CBD. In fact, the company has 16 patents already granted along with more than 60 patents that are pending worldwide (http://ibn.fm/j08G0).

Lexaria has cannabinoid licensing agreements with various companies in North America. The popularity of cannabinoid products such as CBD is likely to increase in the future and the U.S. cannabis market alone is projected to grow substantially in the future (http://ibn.fm/LsBtn). Lexaria’s delivery technology is already being used by the CBD/hemp industry and could experience radical growth in step with the industry.

The DehydraTECH™ drug delivery platform is an innovative technology that was developed as a way to safely and effectively deliver substances both to the bloodstream and to the brain via the oral ingestion route. Substances such as nicotine and cannabidiol are historically inhaled, a choice that is harmful to health compared with non-inhalation methods.

Inhalation can be problematic and dangerous especially for individuals who may have other medical issues. The DehydraTECH™ drug delivery platform can be used to deliver substances in edible or in beverage form, and in capsules, pills, syrups and more. Brands in both Canada and the USA have licensed DehydraTECH™ to make their CBD and cannabis beverages best-in-class.

Not only is ingestion a much safer form of drug delivery, but DehydraTECH™ also delivers the active ingredient of the substance at a rate that is up to five to ten times faster compared with traditional edible products. A 2018 European clinical study demonstrated that 317 percent more CBD was delivered within half an hour when compared with a positive control of equal strength (http://ibn.fm/pXIxY). The substance being delivered is also rapidly absorbed which means that people can achieve the effect they are looking for more quickly than was previously the case with edibles. For people looking for quick relief of pain, DehydraTECH is a blessing.

Many human receptor cells are clustered primarily in the brain or central nervous system, so in order to treat conditions, drugs need to effectively reach these areas of the body which has historically been difficult to do. Research studies done with animals have demonstrated delivery of 1,937 percent more cannabidiol (and over 500 percent more nicotine) into the brain tissue after 8 hours when using the enhanced DehydraTECH™ when compared with using generic industry MCT coconut-oil formulations. Greater effectiveness can mean safer, lower doses. The increased bioavailability and speed of onset are important factors when delivering substances to the brain and is especially important for people who need rapid relief from unpleasant and debilitating symptoms.

Studies done in the laboratory have also shown dramatically improved oral nicotine delivery using the DehydraTECH™ platform. Lexaria has partnered with one of the world’s largest tobacco companies to help fund the research and development of DehydraTECH™ as it relates to nicotine delivery (http://ibn.fm/rlVJn).

A big advantage of the DehydraTECH™ drug delivery platform when it comes to nicotine is that the delivery is fast when compared with other oral forms of nicotine – such as nicotine lozenges or nicotine gum. Users are less likely to get frustrated if they can feel the effects of the nicotine faster when taken in through the oral route. Lower-risk technologies are needed when it comes to nicotine, which is something that the government has recognized since smoking is known to be deadly. Therefore, technology developed to reduce health risks is highly beneficial.

DehydraTECH™ drug delivery platform has applications for the pharmaceutical industry and could be used to deliver fat-soluble drugs. It also could be used to deliver NSAID medications such as ibuprofen or acetylsalicylic acid. DehydraTECH™ has the advantage of allowing substances to bypass first phase liver metabolism.

The technology uses GRAS (Generally Recognized As Safe) food ingredients and further advantages are that the technology removes the bitter flavors and odors of many drugs. This is beneficial because artificial sweeteners do not need to be added to the product to enhance its taste and make it palatable. Sugar may be an issue, especially for people who have diabetes, thus a sugar-free product would be a healthier option.

Lexaria was recently granted two granted patents related to the treatment of heart disease, Alzheimer’s, Parkinson’s and schizophrenia. The treatment of these and other types of neurological disorders in particular has been problematic due to the blood-brain barrier – which makes it difficult for the brain to take up the needed medications. This barrier is formed by endothelial cells which function to prevent dangerous substances from passing into the brain from blood vessels, but the problem is that this also often stops helpful drugs from being able to enter the brain. The patented DehydraTECH™ drug delivery platform helps overcome this limitation to rapidly deliver essential medications to the brain.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at  http://ibn.fm/LXRP

• B2Digital files Form 8-A Registration Statement with SEC; it is now subject to SEC reporting requirements
• The filing enhances B2Digital’s accountability while contributing to increased liquidity
• Three key acquisitions mark B2Digital’s steady progress toward becoming a premier live-event sports company

With an extensive background in entertainment, television, video and technology, B2Digital Inc. (OTC: BTDG) is in the process of developing and acquiring MMA and sports-related companies to become a premier, vertically integrated, live-event sports company. B2Digital took a significant step in that process when it recently filed a Form 8-A Registration Statement with the U.S. Securities and Exchange Commission (SEC) and is now fully reporting.

“We believe that becoming a fully-reporting company subject to the reporting requirements of the SEC shows our commitment to providing current public information to not only our deserving and valued shareholders but to the public, in general,” B2Digital chairman and CEO Greg P. Bell stated in a news release. “Being a fully reporting company with the SEC should also help contribute to increased liquidity for our current and future shareholders and will enhance management’s accountability.”

The SEC filing means that BTDG is now subject to the reporting requirements of the Exchange Act of 1934 as amended, including Form 10-K, Form 10-Q and Form 8-K reporting requirements, as well as additional reporting obligations related to proxies, shareholder actions and stock ownership.

The SEC filing is only the latest in a several milestone moments for B2Digital this year. The company has announced three key acquisitions this year, including the following:

• United Combat League (http://ibn.fm/yhO3P): Through this acquisition, the company acquired four top MMA companies. The United Combat League operates fights in Illinois and Wisconsin.
• Pinnacle Combat (http://ibn.fm/eayag): With this move, B2Digital acquired five top MMA companies. Pinnacle Combat hosts fights in Iowa.
• Strike Hard Productions of Alabama: BTDG recently acquired its sixth top MMA company, Strike Hard Productions, who has held more than 50 LIVE MMA events in Alabama and Mississippi.

With these acquisitions, B2Digital’s B2 Fighting Series brand now includes HRMMA, Colosseum Combat, United Combat League, Pinnacle Combat and StrikeHard Productions fighting companies, as well as MMA news and social media system, Blue Grass MMA. By the end of March 2020, B2 Fighting Series will have scheduled fights in 10 states across the country.

B2Digital is clearing forging toward its goal of becoming a full-service, live-event sports company. Capitalizing on the power of Bell’s expertise and involvement with more than 40,000 live events over his career in major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated premier development league for the multibillion-dollar mixed martial arts industry.

B2Digital also plans to create and develop league champions that will move on to the MMA major leagues from the company’s B2 Fighting Series brand. In addition, B2Digital has deployed its B2 Social Media Network (B2SN) for the B2 Fighting Series. The revolutionary network surpassed 3.8 million social media connections in fiscal Q2 2019, including 64,543 unique users. Those numbers mark the largest audience on B2Sn since the network was launched.

Finally, B2Digital has developed and deployed the systems and technologies for the operation of social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems.

For more information, visit the company’s website at www.B2DigitalOTC.com

NOTE TO INVESTORS: The latest news and updates relating to BTDG are available in the company’s newsroom at http://ibn.fm/BTDG

• OCLN pioneers “instant-infrastructure” products enabling businesses to increase efficiency and asset value
• On-premise, point-of-use water systems enable higher purification and can reduce water costs through reuse
• Self-reliant water management can lead to better Environmental and Social Governance (ESG) ratings

OriginClear (OTC: OCLN), the pioneer in self-reliant water infrastructure, provides innovative water-treatment systems that not only assist companies in increasing their operating efficiency and asset value but also help those companies meet new Environmental and Social Governance (ESG) governance standards. OCLN president and CEO Riggs Eckelberry discussed the company’s involvement in these key areas during an interview on MoneyTV with Donald Baillargeon (http://ibn.fm/H8oac).

“We have this new concept of decentralized water wealth,” Eckelberry stated in the interview. “What does that mean? We know that infrastructure is falling apart, that’s well documented… But what’s happening then is that all the water, wastewater, and water management is falling back on the users. So increasingly corporations, factories, farmers, commercial buildings and so forth have to do their own self-reliant water treatment.

“It’s… an interesting shift of assets,” he continued. “The minute you create these decentralized situations, you’re increasing the asset value of the businesses and their operating efficiency. For example, they recycle better, they have better quality water, and so forth.”

As companies adopt these new water-treatment solutions, they are also meeting new ESG standards, which are fast becoming an invaluable distinction in the investing world. “ESG is a set of investing guidelines being adopted by more and more large funds, family offices, and so forth all over the world,” Eckelberry explained. “Trillions are being invested in companies that are ESG-portfolio companies.”

The opportunity for companies to facilitate their own water treatment, recycle water, and reduce their carbon footprint is a win in all areas, noted Eckelberry. “Now you’re an ESG-portfolio company, and it actually increases your value.”

OCLN is proud of the part it plays in this virtuous process, said Eckelberry, a process that is bringing the company more than just environmental accolades. As OriginClear has carved its niche in the flourishing industry, the company is seeing exciting growth opportunities as it markets water treatment to the end user.

“We’ve taken the central thing and blown it out to the edge, and now that’s created thousands of opportunities where there was one,” explained Eckelberry about the concept of decentralizing water treatment. “And guess what? That one central thing everybody is jumping all over. All the big water companies… let them have it. It’s a dying business. Go to the edge where the new action is, and that’s us.”

MoneyTV is an internationally syndicated television program that features informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures. The show is seen in over 200 million TV households in more than 75 countries.

OriginClear leads the self-reliant water revolution, deploying advanced technologies at the point of use with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture. Failing water infrastructure is increasingly forcing businesses to treat their own water, and OriginClear leads this megatrend with on-premise systems enabling high purification and recycling levels that centralized systems cannot achieve.

For more information, visit the company’s website at www.OriginClear.com

NOTE TO INVESTORS: The latest news and updates relating to OCLN are available in the company’s newsroom at http://ibn.fm/OCLN

• $20 million in deferred revenue expected in early 2020.
• Well-positioned to realize $100 million in revenue by 2021.
• Company is undervalued by a factor of 23, with a market cap of $5.2 million and a share price around $0.13, as of Oct. 14, 2019.
• Creator and co-founder Kirk Shaw has a film production profitability rate of 90%.
• Affiliated with top Hollywood executives, producers and actors.
• 7 productions greenlit, $58 million total budgets.
• Risk-averse production process results in predictable and consistent revenue streams.
• Soaring content demand from streaming providers is fueling industry growth. According to PwC, global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.
• Recent formation of film and television sales and distribution joint venture, Wonderfilm Global, is expected to generate significant incremental revenue.
• Strong relationships throughout industry enable cost-effective production budgets to come together.
• Management team comprised of industry insiders with proven track records.

Wonderfilm Media Corporation’s (TSX.V: WNDR) (OTCQB: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonderfilm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.

Wonderfilm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.

Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.

The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.

Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.

Management Team with Proven Track Records

Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.

Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.

Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.

Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.

Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.

17-Title Movie Slate — Greenlit

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.

Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.

The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.

Potential for Breakout Success

Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.

Note: Potential breakout films are not factored into company’s revenue projections.

Base Hits and Home Runs

In tandem with its slate of high-profile films, Wonderfilm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.

Recent Industry Breakout Films Include:

• SAW – $1.2 million budget = $103.9 million in sales
• Pulp Fiction – $8 million budget = $212 million in sales
• My Big Fat Greek Wedding – $5 million budget = $250 million in sales
• Lost in Translation – $4 million budget = $120 million in sales
• Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)

Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.

Recent Wonderfilm Releases

• 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
• 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
• 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
• 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.

Wonderfilm Global Distribution

At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.

Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.

The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonderfilm projects and, at times, third-party films. The average Wonderfilm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonderfilm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.

A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.

Wonderfilm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.

Wonderfilm Business Model

Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.

Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.

Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.

Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.

Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.

Sales overages once contracted presale threshold is surpassed.

The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.

Note: The nature of the film business is that box office revenue lags production up to a couple of years.

$50 Million Wonderfilm Production Fund (WPF):

Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.

The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.

For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.

All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.

For more information, visit the company’s website at www.Wonderfilm.com

NOTE TO INVESTORS: The latest news and updates relating to WDRFF are available in the company’s newsroom at http://ibn.fm/WDRFF

• Geyser Brands recently received a processing license and implemented manufacturing at a licensed production (LP) facility
• The company developed NanoFusion, an advanced nanotechnology drug-delivery system
• GYSR recently acquired Solace Management Group Inc.

Now that cannabis is losing its illegitimacy, derivatives of the plant are permeating consumer markets at a rapidly growing pace, thanks to companies such as Geyser Brands Inc. (TSX.V: GYSR). The global cannabis-powered and science-led consumer health care company offers products in a diverse range of markets, from fast-moving consumer goods and over-the-counter pharmaceuticals to medical cannabis.

In October 2018, Geyser received its Health Canada cultivation license and, in June 2019, less than a year later, a standard processing license. Licenses for R&D and sales are pending. In addition, the company recently closed an acquisition that considerably increased its brand portfolio. Driven by a management team experienced in manufacturing and marketing, Geyser looks set to realize its vision of being a global player in the billion-dollar cannabis and plant-powered health care markets.

Given the company’s extensive brand portfolio, the world is Geyser’s oyster. GYSR has products in a number of global markets, including the trillion-dollar personal and skin-care market; the $575 billion personalized and complementary medicine market; the ballooning (CAGR 34.6 percent) legal-marijuana market, which has been forecasted to reach $146 billion by 2025; the $4.2 trillion wellness market; and the pet care market, which is worth around $132 billion.

Geyser recently closed on its acquisition of established hemp-brands manufacturer Solace Management Group Inc., which added two dozen wellness products and 57 SKUs to GYSR’s product lineup. The acquisition also comes with a 7,500-square-foot, GMP-compliant facility belonging to an existing innovation-hub and manufacturing subsidiary in Coquitlam, British Columbia (http://ibn.fm/StIcV).

Solace also owns a number of brands with leading market positions in Canada, including Apawthecary Pets, WildTails pet products, Apothecary Naturals and Apothecary Ink, all of which currently use hemp oil in their formulations. The brands are distributed by leading retailers across Canada including Bosley’s and Shoppers Drug Mart. In addition, Solace recently received approval for sales of a new pain-relief, roll-on product thanks to a natural product number issued by Health Canada (http://ibn.fm/yXFxK).

And that’s not the only good news for Geyser. In June 2019, Apothecary Botanicals, Geyser’s wholly owned licensed producer (LP), received a standard processing license from Health Canada, a key development that allows the production of a variety of products including tinctures and supplements (http://ibn.fm/Iym76).

In addition, Geyser has developed NanoFusion, an advanced nanotechnology drug-delivery system that transports therapeutic agents rapidly and efficiently directly to the bloodstream for maximum absorbency. In the past, a major challenge in producing cannabinoids for ingestion or absorption through the skin is their insolubility.

Cannabinoids are naturally hydrophobic (afraid of water), which makes it harder for the body to absorb them. The result is inconsistent, unreliable dosing and onset times of up to three hours. Geyser’s NanoFusion breaks down cannabinoid particles and combines them with naturally occurring surfactants that lower the surface tension between cannabinoids and water, resulting in a compound that is water compatible.

For more information, visit the company’s website at www.GeyserBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR